M&A Deal Summary

Raybow Pharmaceutical Acquires PharmAgra Labs

On November 4, 2019, Raybow Pharmaceutical acquired life science company PharmAgra Labs

Acquisition Highlights
  • This is Raybow Pharmaceutical’s 1st transaction in the Life Science sector.
  • This is Raybow Pharmaceutical’s 1st transaction in the United States.
  • This is Raybow Pharmaceutical’s 1st transaction in North Carolina.

M&A Deal Summary

Date 2019-11-04
Target PharmAgra Labs
Sector Life Science
Buyer(s) Raybow Pharmaceutical
Deal Type Add-on Acquisition

Target

PharmAgra Labs

Brevard, North Carolina, United States
PharmAgra Labs, Inc. is an agile, results-based contract chemistry company that provides comprehensive services, including pharmaceutical ingredient manufacturing services. conform to good manufacturing practices (cGMP), custom synthesis, process development, and analysis. PharmAgra Labs is based in Brevard, North Carolina.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Raybow Pharmaceutical

Taizhou, China

Category Company
Sector Chemicals
DESCRIPTION

Raybow Pharmaceutical manufactures advanced chemical intermediates, regulatory raw materials and active pharmaceutical ingredients in a US FDA-inspected facility in Taizhou, China.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: North Carolina M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1